Efficacy and Safety of Esaxerenone in Hypertensive Patients with Diabetes Mellitus Undergoing Treatment with Sodium-Glucose Cotransporter 2 Inhibitors (EAGLE-DH)-Reference-Cited by-同舟云学术

Efficacy and Safety of Esaxerenone in Hypertensive Patients with Diabetes Mellitus Undergoing Treatment with Sodium-Glucose Cotransporter 2 Inhibitors (EAGLE-DH)

Published:2023-09-21 Issue:11 Volume:40 Page:5055-5075
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Motoki Hirohiko,Inobe Yoshito,Fukui Toshiki,Iwasaki Arata,Hiramitsu Shinya,Koyama Sekiya,Masuda Izuru,Sekimura Noriyuki,Yamamoto Kazuya,Sato Ai,Komatsu Mitsuhisa,Taguchi Takashi,Shiosakai Kazuhito,Sugimoto Kotaro,Kuwahara Koichiro

Funder

Daiichi-Sankyo

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12325-023-02633-8.pdf

Reference55 articles.

1. Petrie JR, Guzik TJ, Touyz RM. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can J Cardiol. 2018;34:575–84.

2. Khan MAB, Hashim MJ, King JK, et al. Epidemiology of type 2 diabetes—global burden of disease and forecasted trends. J Epidemiol Glob Health. 2020;10:107–11.

3. Buford TW. Hypertension and aging. Ageing Res Rev. 2016;26:96–111.